Rafael Venta

Rafael Venta

Auto-generated profile, based on publicly available information

Rafael Venta

D Service of Biochemistry, Hospital San Agustín, Avilés 33401, Spain

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2009 in Medicine & Science in Sports & Exercise
Verified
Journal Article
Closed access
RVRafael Venta
Rafael Venta
ECElena Cruz
Elena Cruz
GVGracia Valcárcel
Gracia Valcárcel
Nicolas TerradosNicolas Terrados
Nicolas Terrados
The effect of different acute aerobic intense exercises on plasma, reduced, and total Hcy (rHcy, tHcy) and cysteine (rCys, tCys) and on its metabolically related vitamins and amino acids. Parallel effects on renal function were assessed by plasma creatinine. Methods: Fifteen cyclists and 14 kayakers were examined before and 30 ± 5 min after a specific test to exhaustion during a low-intensity training period. Results: After a bout of specific exercise, the concentrations of aminothiols were increased regardless of the group considered. Plasma concentrations were higher than baseline values in tHcy (17.7 ± 1.5%; P < 0.001), rHcy (10.6 ± 1.6%; P < 0.001), tCys (9.9 ± 1.6%; P < 0.001), and rCys (7.6 ± 2.2%; P < 0.01). Both groups showed significant elevations of pyridoxal-5′-phosphate (PLP; P < 0.01), vitamin B12 (P < 0.001), and creatinine concentrations (P < 0.001) after acute exercises, but no changes were seen in folate. Changes in plasma aminothiols after exercise did not reach significant correlation with changes in free amino acids or baseline vitamins, but significant and positive correlations were observed with changes in plasma PLP, vitamin B12, and creatinine concentrations, when the pooled data were considered. Conclusions: Our results show that higher plasma concentrations of tHcy after an acute intense exercise are associated to higher concentrations of rHcy, and this effect is independent of the type of exercise, vitamin status, or amino acid metabolic stress but could be related to potential changes in the renal function....

8 July 2014 in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
Verified
Journal Article
Closed access
ZCZoraida Corte
Zoraida Corte
CGCamino García
Camino García
RVRafael Venta
Rafael Venta
Background: Serum cardiac troponin T concentrations are important predictors of cardiovascular and all-cause mortality in end-stage renal disease. In patients with end-stage renal disease, assessment of serial results is essential to distinguish between a cardiovascular event and chronic elevation. We employed a high-sensitivity serum cardiac troponin T assay to evaluate the long-term biological variation in end-stage renal disease patients and in healthy individuals; these biological variation data were used to define the reference change value and the analytical goals. Methods: Serum samples were collected from 18 end-stage renal disease patients in steady-state conditions, one per month for 6 months, and from 11 healthy volunteers at weekly intervals over 5 weeks. Biological variation data were derived using analysis of variance. Results: Baseline serum cardiac troponin T concentrations in end-stage renal disease patients were above the 99th percentile of the healthy population and increased with duration of haemodialysis. For end-stage renal disease patients, within-subject (CV I ) and between-subject (CV G ) coefficients of variation were 14.7 and 77.8%, respectively, whereas these were 5.9 and 30.4%, respectively, for healthy individuals. The derived two-tailed and one-tailed reference change values were 44.1 and 37.1%, respectively, for end-stage renal disease patients, and 21.6 and 18.2% for healthy subjects. Conclusions: For appropriate clinical management of end-stage renal disease patients in the context of a cardiovascular event, regular monitoring of serum cardiac troponin T concentrations could be important in order to allow future comparison through reference change value. Biological variation data in end-stage renal disease patients were significantly higher than for healthy individuals; therefore, the use of proper reference change value data is recommended. Moreover, the observed CV I values provide demanding imprecision goals for current technology.

25 November 2009 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
ZCZoraida Corte
Zoraida Corte
RVRafael Venta
Rafael Venta
Background: Biological variation data for free plasma amino acids are lacking from the more comprehensive databases. Therefore, we determined the intra- and inter-individual components of variation in healthy subjects. These data were used to define desirable goals for imprecision, bias and total error, indices of individuality and reference change values. Methods: Plasma samples were collected from 11 volunteers at weekly intervals over 5 weeks. Free plasma amino acids were analyzed by reversed-phase HPLC and analytical and biological variation data were derived using ANOVA. Results: Intra-individual coefficients of variation ranged from 9.5% to 46.4%, with lower values among the essential amino acids. The mean inter-individual coefficient of variation was 46.6% and was higher than intra-individual values for all amino acids. Thus, indices of individuality were below 0.8. Reference change values ranged from 30.9% to 128.4% and total error values ranged from 15.2% to 61.0%. Conclusions: Plasma amino acids exhibit relatively low intra-individual coefficients of variation, with essential amino acids showing tighter homeostatic control. Analytical quality goals can be reasonably achieved with current methods. Reference intervals are of limited value in the detection of unusual results in an individual. Therefore, comparison of serial results by means of the reference change values is recommended. Clin Chem Lab Med 2010;48:99–104.

1 January 2009 in European Journal of Radiology
Verified
Journal Article
Closed access
DPDiego Pidal
Diego Pidal
MVMª Teresa Sánchez Vidal
Mª Teresa Sánchez Vidal
JRJuan Carlos Rodríguez
Juan Carlos Rodríguez
MCMª Daniela Corte
Mª Daniela Corte
PPPaz Pravia
Paz Pravia
FVFrancisco J. Vizoso
Francisco J. Vizoso

6 February 2001 in Prenatal Diagnosis
Verified
Journal Article
Closed access
PDF file
RARebeca Alonso-Arias
Rebeca Alonso-Arias
APAna Paz
Ana Paz
RVRafael Venta
Rafael Venta
JLJack H. Ladenson
Jack H. Ladenson
BPBelén Prieto
Belén Prieto
FÁFrancisco V. Álvarez
Francisco V. Álvarez

1 June 2011 in Anales de Pediatría
Verified
Journal Article
Closed access
FCF. Álvarez Caro
F. Álvarez Caro
JDJuan José Díaz
Juan José Díaz
IRIsolina Riaño-Galan
Isolina Riaño-Galan
David Pérez SolísDavid Pérez Solís
David Pérez Solís
ROR. Venta Obaya
R. Venta Obaya
SGS. Málaga Guerrero
S. Málaga Guerrero